US2016346392A1PendingUtilityA1
Pulse photodynamic treatment of skin conditions
Est. expiryDec 20, 2033(~7.4 yrs left)· nominal 20-yr term from priority
Inventors:Hans Christian Wulf
A61P 43/00A61P 35/00A61P 17/02A61P 17/16A61P 17/10A61P 17/00A61M 2037/0007A61K 31/22A61K 41/0061A61N 5/062A61K 31/197A61N 2005/0652A61N 2005/0653A61M 2037/0061A61N 2005/0663A61M 2037/0023A61M 37/00A61M 37/0015A61N 2005/0657
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A pulse photodynamic therapy (or pulse PDT) treatment of skin complaints is described herein. The skin complaint being treated can be actinic keratosis (AK) or a basal cell carcinoma (BCC).
Claims
exact text as granted — not AI-modified1 . A method of treating a skin condition in an animal the method comprising adminisering a photosensitizer to the animal skin, wherein the photosensitizer treats the skin condition with photodynamic therapy (PDT), and wherein the photosensitizer is applied to the skin of the animal for a short period of time, and the skin condition is actinic keratosis or basal cell carcinoma.
2 . The method according to claim 1 , wherein the method reduces side effects associated with PDT.
3 . The method according to claim 1 , further comprising applying the photosensitizer to the skin of the animal for a period of from 5 minutes to 120 minutes.
4 . The method according to claim 1 , wherein the PDT includes a photoactivation achieved by artificial or natural light source.
5 . The method according to claim 1 , wherein the PDT comprises:
a) administering to the animal a composition comprising the photosensitizer for a duration of from 5 minutes to 120 minutes; and b) photoactivating the photosensitizer for a duration of from 1 minute to 15 minutes with artificial light or from 0.5 hour to 3 hours with natural light.
6 . The method according to claim 5 , wherein the PDT comprises:
a) administering to the animal a composition comprising the photosensitizer for a duration of from 15 minutes to 60 minutes; and b) photoactivating the photosensitizer for a duration of from 5 minutes to 10 minutes with artificial light or from 0.5 hour to 2 hours with natural light.
7 . The method according to claim 6 , wherein PDT comprises:
a) administering to the animal a composition comprising the photosensitizer for a duration of 30 minutes; and b) removing the photosensitizer; and c) photoactivating the photosensitizer 2.5 hours later for a duration of 9 minutes with artificial light or of at least 2 hours with natural light.
8 . The method according to claim 1 , wherein the photosensitizer is selected from the group consisting of 5-ALA, 5-ALA derivatives, 5-MAL, 5-MAL derivatives, and compounds covered by general formula I:
R 2 2 N—CH 2 COCH 2 —CH 2 CO—OR 1 (I)
wherein: R 1 represents a substituted or unsubstituted straight, branched or cyclic alkyl group; and each R 2 independently represents a hydrogen atom or an optionally substituted alkyl group; and pharmaceutically acceptable salts thereof.
9 . The method according to claim 1 , wherein the photosensitizer is 5-ALA or 5-methyl ALA ester.
10 . The method according to claim 1 , wherein administering the photosensitizer to the animal is carried out with or without occlusion.
11 . The method according to claim 1 , wherein the photosensitizer is used in combination with a glucocorticosteroid.
12 . The method according to claim 3 , wherein the period of time is from 15 minutes to 60 minutes.
13 . The method according to claim 4 , wherein the artificial or natural light source is a LED or sunlight.
14 . The method according to claim 8 , wherein the alkyl group is a substituted or unsubstituted straight-chained alkyl group.
15 . The method according to claim 10 , wherein the administration of the photosensitizer is carried out with occlusion.Join the waitlist — get patent alerts
Track US2016346392A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.